stonks4u
Log inSign up free
STLN logo

STLN Starling Oncology, Inc.

NASDAQ · Medical - Care Facilities · Healthcare

$6.57
+0.12 (+1.89%)

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across m…

Market Cap: $657.11Mwww.starlingoncology.com

Price

No data yet.

Signal Score (90d)

100
100
Aug 17Aug 17

Quote

Day Range
$6.48 – $6.67
52-Week Range
$2.32 – $7.05
Volume
$210.0K
Market Cap
$657.11M
50-Day Avg
$5.40
200-Day Avg
$3.93
Prev Close
$6.45
Open
$6.50

Valuation & Ratios

P/E Ratio
-10.74
EPS
$-0.66
P/B Ratio
-34.09
P/S Ratio
1.07
Debt/Equity
-6.60
Current Ratio
1.59
Dividend Yield
+0.0%
Gross Margin
+15.2%

Returns & Efficiency

Return on Equity
+385.5%
Return on Assets
-36.8%
FCF Yield
-5.2%
EV/EBITDA
-14.25

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$502.73M$-60.61M$-0.54

Social Signal Score

50
5d
51
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1

Earnings

1of 4 quarters beat consensus

Typical surprise -25.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$-0.08 vs $-0.06miss
  • Thu, May 7$-0.02 vs $-0.09beat
  • Wed, Aug 13$-0.15 vs $-0.12miss
  • Tue, Aug 13$-0.17 vs $-0.09miss

Estimates and results for STLN via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Insider trading

Open-market buys and sells by STLN officers and directors.

Bought
$78k

1 trade

Sold
$900

1 trade

  • Chernett Joreybought
    10 percent owner·12,000 @ $6.54·$78k·Aug 14, 2026·filing
  • Chernett Joreysold
    10 percent owner·100 @ $9.00·$900·Aug 13, 2026·filing

Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.

Valuation

STLNhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsglobenewswire.com·6h ago·Neutral

    … Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale CERRITOS, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™ Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced the launch of Starling Oncology Nexus, a proprietary technology platform built to address one of cancer care's persistent challenges: NCCN compliance by the medical community and a fragmented and administr…

    View source ↗